RAYT Rayont

Rayont Inc- RAYT- Announces the Sale of NGPDT License for Sub-Sahara Africa and equipment to Nova Medical Group Pty Ltd.

Rayont Inc- RAYT- Announces the Sale of NGPDT License for Sub-Sahara Africa and equipment to Nova Medical Group Pty Ltd.

Palo Alto, California, June 29, 2022 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC QB: RAYT), an international healthcare company specializing in the manufacturing, distribution of alternative medicine products and services across the entire value chain, announced that on 29 of June 2022 it has signed the Asset Sale Agreement for sale of Next Generation Photo Dynamic Therapy (NGPDT) License for Sub-Sahara Africa and its equipment.

The sale as described in Asset Sale Agreement between Rayont (Australia) Pty Ltd (“Asset Seller”), Rayont International (L) Limited (“License Seller”) and Nova Medical Group Pty Ltd (“Buyer”) is for a consideration of USD 3,500,000 or equivalent to AUD 5,000,000 where the consideration is split as follows:

• License for Sub-Sahara Africa – USD 2,500,000

• Equipment – USD 1,000,000

The company shall file an 8K with The Securities and Exchange Commission within time required to disclose the details of the deal.

“The decision to sell NGPDT License and equipment was a difficult one given the promise the technology could offer to cancer patients. This sale following the sale of Rayont Technologies earlier this year is a clear indication of our strategic intent to focus of Complementary Alternative Medicine and profit generating assets within the segment. The cash to be generated over time from this sale improves the cash position and liquidity of Rayont Group” said Rayont’s President & CEO, Ms Marshini Aliya Moodley.

About Rayont Inc.

Rayont, Inc. (RAYT) is a public traded company incorporated in Nevada, USA since its inception in 2011. In 2018, the Company repositioned itself to focus on healthcare including the manufacturing and, distribution of alternative medicine products and services across the entire value chain.

Over past few year the Company has built a portfolio of businesses focusing on natural and alternative medicine products and services, personalized healthcare for patients based on scientific reliable tests aimed to provide positive results to improve the patients` healthcare and quality of life.

For further information, please visit 

SAFE HARBOR

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Company Contact:

Investor Relations



EN
29/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Rayont

 PRESS RELEASE

Rayont Inc- RAYT- Reports 10-Q for the Six -Month Ending December 31, ...

Rayont Inc- RAYT- Reports 10-Q for the Six -Month Ending December 31, 2022, Financial Results. Palo Alto, California, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international personalized natural healthcare company, today reported financial results for the six-month ended December 31, 2022. Business Highlights Within the Six-Month ended December 31, 2022: Ms. Marshini Moodley, CEO and CFO, said, “We recorded an increase in both the revenue and gross profit for the period ended December 31, 2022 compared to same period last ...

 PRESS RELEASE

Rayont Inc- RAYT- Reports 10-Q for the Three -Month Ending September 3...

Rayont Inc- RAYT- Reports 10-Q for the Three -Month Ending September 30, 2022, Financial Results. Palo Alto, California, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international personalized natural healthcare company, today reported financial results for the three-month ended September 30, 2022. Business Highlights Within the Three-Month ended September 30, 2022: Ms. Marshini Moodley, CEO and CFO, said, “We recorded an increase in both the revenue and gross profit for the period ended September 30, 2022 compared to same period last ye...

 PRESS RELEASE

Rayont Inc- RAYT- Reports 10-K for the Twelve -Month Ending June 30, 2...

Rayont Inc- RAYT- Reports 10-K for the Twelve -Month Ending June 30, 2022, Financial Results. Palo Alto, California, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international personalized natural healthcare company, today reported financial results for the twelve-month ended June 30, 2022. Business Highlights Within the Twelve-Month ended June 30, 2022: Ms. Marshini Moodley, CEO and CFO, said, “We recorded a decline in both the revenue and gross profit for the period ended 30 June 2022 compared to same period last year, mainly d...

 PRESS RELEASE

Rayont Inc- RAYT- Announces Acquisition of The SkinDNA Company to beco...

Rayont Inc- RAYT- Announces Acquisition of The SkinDNA Company to become a global leader in personalized wellness. Palo Alto, California, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international integrative healthcare and wellness company, today completed the acquisition of The Skin DNA Company, (SkinDNA®), a pioneering brand behind the multi-award-winning skin DNA testing technology SkinDNA® since its conception in 2008. Under the agreement Rayont Inc., through its wholly owned subsidiary Rayont Australia Pty Ltd, acquired 100% of the ...

 PRESS RELEASE

Rayont Inc- RAYT- Announces the Sale of NGPDT License for Sub-Sahara A...

Rayont Inc- RAYT- Announces the Sale of NGPDT License for Sub-Sahara Africa and equipment to Nova Medical Group Pty Ltd. Palo Alto, California, June 29, 2022 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC QB: RAYT), an international healthcare company specializing in the manufacturing, distribution of alternative medicine products and services across the entire value chain, announced that on 29 of June 2022 it has signed the Asset Sale Agreement for sale of Next Generation Photo Dynamic Therapy (NGPDT) License for Sub-Sahara Africa and its equipment. The sale as descr...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch